Global Biopreservation Market

Global Biopreservation Market Size, Share, Growth Analysis, By Product(Equipment, Media), By Application(Regenerative Medicine, Bio-banking) - Industry Forecast 2024-2031


Report ID: SQMIG35I2223 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 63 | Figures: 75

Global Biopreservation Market Dynamics

Global Biopreservation Market Drivers

Increasing Demand for Personalized Medicine

  • The growing focus on personalized medicine and individualized therapies has fueled the demand for biopreservation solutions. Biopreservation techniques are crucial for preserving biological samples, including cells, tissues, and organs, for research, diagnosis, and treatment purposes.

Global Biopreservation Market Restraints

High Costs

  • Biopreservation technologies and services can be expensive, particularly for long-term storage and large-scale biobanking activities. The high costs associated with equipment, maintenance, and operational requirements can act as a restraint, limiting the adoption of biopreservation solutions, especially in resource-constrained settings.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Biopreservation Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 20.54 billion by 2031, growing at a CAGR of 28.30% during the forecast period (2024-2031).

Strategic initiatives, finance facilities for regional expansion, partnerships, and acquisitions in important areas are being pursued by market participants. For example, Hamad Medical Corporation & Qatar BioBank introduced an innovative tissue biobank facility in Qatar in January 2023 to provide researchers with access to high-quality tissue samples. 'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'BioLife Solutions, Inc.', 'GE Healthcare', 'VWR International LLC', 'Custom Biogenic Systems, Inc.', 'Chart Industries, Inc.', 'BioCision LLC', 'STEMCELL Technologies Inc.', 'Cesca Therapeutics Inc.', 'Core Dynamics Ltd.', 'Panasonic Healthcare Co., Ltd.', 'Avantor, Inc.', 'Lonza Group Ltd.', 'Brooks Automation, Inc.', 'BioStorage Technologies, Inc.', 'LabVantage Solutions, Inc.', 'Atlanta Biologicals, Inc.', 'Hamilton Company', 'So-Low Environmental Equipment Co.'

The growing focus on personalized medicine and individualized therapies has fueled the demand for biopreservation solutions. Biopreservation techniques are crucial for preserving biological samples, including cells, tissues, and organs, for research, diagnosis, and treatment purposes.

Growing Demand for Cell-based Therapies: The biopreservation market is witnessing a significant surge in demand for cell-based therapies, such as stem cell therapies and CAR-T cell therapies. Biopreservation plays a crucial role in preserving the viability and functionality of cells during storage and transportation, driving the need for advanced biopreservation techniques and solutions.

North America represented a 45.00% revenue share in the biological preservation market in 2022. This can be ascribed to advancements in medical studies and the creation of improved medicines. Furthermore, the increasing number of chronic occurrences that require treatment raises demand for biological preservation in the region, which enhances its market position.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biopreservation Market

Product ID: SQMIG35I2223

$5,300
BUY NOW GET FREE SAMPLE